Vital Therapies' Series D - II Round

Vital Therapies raised a round of funding on February 17, 2012. Investors include Valley Ventures.

Vital Therapies is a development-stage biotechnology company developing ELAD, an extracorporeal liver support system which functions by processing toxins and synthesizing proteins and metabolites that…

Articles about Vital Therapies' Series D - II Round: